Doug Brenneke, Belden’s vice president of research and development, says the company has faced a severe shortfall of workers for at least two years. Meanwhile, the drug test failure rate has nearly tripled.

Doug Brenneke, Belden’s vice president of research and development, says the company has faced a severe shortfall of workers for at least two years. Meanwhile, the drug test failure rate has nearly tripled.